Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Arrel Olano, MD
Medstar Health Research Institute
Principal Investigator - Judith Cullinane, MSN
Tufts Medical Center
Principal Investigator - Rehan Qayyum, MD
Virginia Commonwealth University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medstar Health Research Institute
Washington D.C., District of Columbia, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Nov 2017
- Primary completion
- 25 May 2018
- Completion
- 30 Jun 2018
- Last update posted
- 11 Apr 2019
- Registered enrollment
- 80
- Registry id
- NCT03332147
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.